Multidrug-resistant tuberculosis of the spine in children-characteristics from a high burden setting

Journal of Tropical Pediatrics

Volumn 58, Issue 5, 2012, Pages 341-347

  Seddon, James A ^a,b   Donald, Peter R ^c   Vlok, Gert J ^a,c   Schaaf, H Simon ^b,c  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CAPREOMYCIN; ETHAMBUTOL; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; TERIZIDONE;

ARTICLE; CHILD; CHILDHOOD MORTALITY; CLINICAL ARTICLE; DELAYED DIAGNOSIS; DRUG MEGADOSE; FEMALE; HUMAN; MALE; MEDICAL RECORD REVIEW; MULTIDRUG RESISTANT TUBERCULOSIS; PEDIATRIC HOSPITAL; SCHOOL CHILD; TUBERCULOUS SPONDYLITIS;

ADOLESCENT; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SOUTH AFRICA; SPINE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, SPINAL;

EID: 84867350328     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmr104     Document Type: Article

References (40)

1. World Health Organisation. Multidrug and extensively drug-resistant TB (M/XDR-TB) 2010 Global report on surveillance and response 2010: (WHO/HTM/TB/ 2010.2013), Geneva, Switzerland.
2. Marais BJ, Hesseling AC, Gie RP, et al. The burden of childhood tuberculosis and the accuracy of communitybased surveillance data. Int J Tuberc Lung Dis 2006;10: 259-63.
3. Marais BJ, Obihara CC, Warren RM, et al. The burden of childhood tuberculosis: a public health perspective. Int J Tuberc Lung Dis 2005;9:1305-13.
4. Walls T, Shingadia D. Global epidemiology of paediatric tuberculosis. J Infect 2004;48:13-22.
5. Schaaf HS, Shean K, Donald PR. Culture-confirmed multidrug-resistant tuberculosis: diagnostic delay, clinical features, and outcome. Arch Dis Child 2003;88: 1106-11.
6. Health Systems Trust. Incidence of TB (all types) per 100000. 2009. http://www.hst.org.za/healthstats/16/ data. (24 February 2011, date last accessed).
7. Schaaf HS, Marais BJ, Hesseling AC, et al. Surveillance of antituberculosis drug resistance among children from the Western Cape Province of South Africa-an upward trend. Am J Public Health 2009;99:1486-90.
8. Barnard M, Albert H, Coetzee G, et al. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 2008;177:787-92.
9. Nathanson E, Gupta R, Huamani P, et al. Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative. Int J Tuberc Lung Dis 2004;8:1382-1384.
10. Orenstein EW, Basu S, Shah NS, et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis 2009;9:153-61.
11. Baquero-Artigao F, Garcia-Miguel MJ, Merino R, et al. Multidrug-resistant tuberculosis of the ankle: Case report. Foot Ankle Int 2006;27:642-4.
12. Pavlopoulou ID, Theodoridou M, Daikos GL, et al. Drug-resistant tuberculous mastoiditis in 2 children. Scand J Infect Dis 2000;32:436-8.
13. Rodriguez L, Weinberg B, Benaroya A, Gertner M. Multidrug-resistant tuberculous osteomyelitis. Pediatr Infect Dis J 1997;16:1096-6.
14. Inselman LS, DelaVega CE, Evans HE. Drug-resistant tuberculosis of the hip in a child. NY State J Med 1984; 84:84-5.
15. Khan SA, Varshney MK, Hasan AS, et al. Tuberculosis of the sternum. J Bone Joint Surg Br 2007;89:817-20.
16. Polley P, Dunn R. Noncontiguous spinal tuberculosis: Incidence and management. Eur Spine J 2009;18: 1096-1.
17. Sandher DS, Al-Jibury M, Paton RW, Ormerod LP. Bone and joint tuberculosis. J Bone Joint Surg Br 2007;89:1379-81.
18. Peto HM, Pratt RH, Harrington TA, et al. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis 2009;49: 1350-7.
19. Lindquist SW, Steinmetz BA, Starke JR. Multidrugresistant tuberculosis of the first cervical vertebra in an immunocompetent adolescent. Pediatr Infect Dis J 1997;16:333-6.
20. Hussey G, Kibel M, Parker N. Ciprofloxacin treatment of multiply drug-resistant extrapulmonary tuberculosis in a child. Pediatr Infect Dis J 1992;11:408-9.
21. Agashe V, Shenai S, Mohrir G, et al. Osteoarticular tuberculosis-diagnostic solutions in a disease endemic region. J Infect Dev Ctries 2009;3:511-6.
22. Pawar UM, Kundnani V, Agashe V, Nene A. Multidrug-resistant tuberculosis of the spine-is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients. Spine 2009;34:E806-10.
23. Bailey HL, Gabriel M, Hodgson AR, Shin JS. Tuberculosis of the spine in children. Operative findings and results in one hundred consecutive patients treated by removal of the lesion and anterior grafting. J Bone Joint Surg Am 1972;54:1633-57.
24. Luk KD. Tuberculosis of the spine in the new millennium. Eur Spine J 1999;8:338-45.
25. Hodgson AR, Skinsnes OK, Leong CY. The pathogenesis of Pott's paraplegia. J Bone Joint Surg Am 1967;49: 1147-56.
26. Leong JC. Tuberculosis of the spine. J Bone Joint Surg Br 1993;75:173-5.
27. Hsu LC, Cheng CL, Leong JC. Pott's paraplegia of late onset. The cause of compression and results after anterior decompression. J Bone Joint Surg Br 1988;70: 534-8.
28. Hazra A, Laha B. Chemotherapy of osteoarticular tuberculosis. Indian J Pharmacol 2005;37:5-12.
29. Ramachandran S, Clifton IJ, Collyns TA, et al. The treatment of spinal tuberculosis: a retrospective study. Int J Tuberc Lung Dis 2005;9:541-4.
30. British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society. Thorax 1998;53:536-48.
31. National Institute for Health and Clinical Excellence. Tuberculosis. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. NICE clinical guideline 2011;117.
32. American Thoracic Society, CDC, and Infectious Diseases Society of America. Treatment of Tuberculosis. MMWR 2003;52:1-74.
33. American Academy of Pediatrics. Tuberculosis. In: Pickering LK, Baker CJ, Long SS, McMilan JA (eds) Red Book: 2006 Report of the Committee on Infectious Dieseases, 27th edn, Elk Grove Village, IL: American Academy of Pediatrics; 2006, 678-704.
34. World Health Organisation, Geneva, Switzerland. Guidance for National Tuberculosis Programmes on the management of tuberculosis in children. WHO/ HTM/TB/2006.371, WHO/FCH/CAH/2006.7. 2006.
35. World Health Organisation. Rapid Advice. Treatment of tuberculosis in children. WHO/HTM/TB/2010.13. 2010. Geneva, Switzerland.
36. Ge Z, Wang Z, Wei M. Measurement of the concentration of three antituberculosis drugs in the focus of spinal tuberculosis. Eur Spine J 2008;17:1482-7.
37. Meissner A, Borner K, Koeppe P. Concentrations of ofloxacin in human bone and in cartilage. J Antimicrob Chemother 1990;26(Suppl D):69-74.
38. Tuli SM, Kumar K, Sen PC. Penetration of antitubercular drugs in clinical osteoarticular tubercular lesions. Acta Orthop Scand 1977;48:362-8.
39. Holdiness MR. Clinical pharmacokinetics of the antituberculosis drugs. Clin Pharmacokinet 1984;9:511-44.
40. Liu P, Zhu Q, Jiang J. Distribution of three antituberculous drugs and their metabolites in different parts of pathological vertebrae with spinal tuberculosis. Spine (Phila Pa 1976) 2011;36:E1290-5.